ArticleScientific reports2026
Federated MobileNetV2 with ensemble meta-learning for privacy-preserving brain tumor classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The identification of brain tumors from MRI images is very crucial for the selection of an appropriate treatment. However, the existing solution has issues with privacy and data sharing. To address this challenge, this paper proposes the use of federated learning. The proposed solution employs a light convolutional backbone and some adaptive local meta-learners. The proposed solution employs MobileNetV2 as the feature extractor. This is fine-tuned for many clients using a combination of FedAvg and FedProx regularization. Each client also trains a few meta-learners (MLP, SVM, and ELM) using the local feature embeddings, enabling people to obtain personalized predictions without sharing their private information. For inference, the framework supports both probability-level averaging across client ensembles and deployable single-client prediction using only the local meta-learners of one client. On the Brain Tumor MRI Dataset, containing 7023 image slices across glioma, meningioma, no tumor, and pituitary classes, the proposed framework achieved a maximum observed accuracy of 99.57%. Across four repeated runs, it achieved 99.29% +/- 0.20% accuracy with a 95% confidence interval of 98.97% to 99.61%, while maintaining strong macro-F1 performance and a macro-average ROC-AUC of 0.998690. Under the same preprocessing and split protocol, it outperformed internally reimplemented CNN+FedAvg and CNN+FedAvg+FedProx baselines and preserved near-centralized ROC-AUC performance. Communication analysis showed that exchanging the MobileNetV2 backbone required 149.89 MB per round for five clients, corresponding to an 83.34% reduction relative to a ResNet-50 backbone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.